PT1250133E - Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto - Google Patents

Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto

Info

Publication number
PT1250133E
PT1250133E PT01906672T PT01906672T PT1250133E PT 1250133 E PT1250133 E PT 1250133E PT 01906672 T PT01906672 T PT 01906672T PT 01906672 T PT01906672 T PT 01906672T PT 1250133 E PT1250133 E PT 1250133E
Authority
PT
Portugal
Prior art keywords
compositions
contact lenses
antialergic
properties suitable
ophthalmic properties
Prior art date
Application number
PT01906672T
Other languages
English (en)
Portuguese (pt)
Inventor
John M Yanni
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of PT1250133E publication Critical patent/PT1250133E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT01906672T 2000-01-25 2001-01-24 Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto PT1250133E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17780400P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
PT1250133E true PT1250133E (pt) 2005-05-31

Family

ID=22650044

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01906672T PT1250133E (pt) 2000-01-25 2001-01-24 Composicoes antialergicas oftalmicas adequadas a utilizacao com lentes de contacto

Country Status (10)

Country Link
US (1) US6375973B2 (enExample)
EP (1) EP1250133B1 (enExample)
JP (2) JP2003520813A (enExample)
AT (1) ATE291913T1 (enExample)
AU (1) AU776789B2 (enExample)
CA (1) CA2395866C (enExample)
DE (1) DE60109742T2 (enExample)
ES (1) ES2236180T3 (enExample)
PT (1) PT1250133E (enExample)
WO (1) WO2001054687A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
US8349352B2 (en) * 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
MX2007009417A (es) * 2005-02-04 2007-08-17 Univ Auburn Sistema de suministro de farmaco de contacto.
US7947010B2 (en) 2005-07-08 2011-05-24 Depuy Products, Inc. Composition and system for wound decontamination
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US20080138408A1 (en) * 2006-11-13 2008-06-12 Siddharth Venkatesh Drug delivery system and method
WO2008097220A1 (en) * 2007-02-07 2008-08-14 Alcon, Inc. Olopatadine formulations for topical nasal administration
EP2595603A1 (en) * 2010-07-21 2013-05-29 Alcon Research, Ltd. Pharmaceutical composition with enhanced solubility characteristics
TWI544922B (zh) * 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
CA2929074A1 (en) * 2013-10-31 2015-05-07 Nephron Pharmaceuticals Corporation Formulation of olopatadine
EP3037094A1 (en) * 2014-12-23 2016-06-29 Poifa Warszawa SA Ophthalmic pharmaceutical composition
CN107875119B (zh) * 2017-11-22 2021-03-12 山东绅联药业有限公司 一种富马酸依美斯汀水性药物组合物及其制备方法
WO2025137749A1 (pt) * 2023-12-27 2025-07-03 Eurofarma Laboratórios S.A. Processo de solubilização de olopatadina e seu uso

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
JPS5879983A (ja) 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPH08770B2 (ja) * 1985-12-25 1996-01-10 千寿製薬株式会社 眼科用組成物
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5037647A (en) * 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
AU636685B2 (en) * 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
US5192780A (en) 1989-12-18 1993-03-09 Alcon Laboratories, Inc. Methods using antiallergics and antihistamines
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
DE69333850T3 (de) 1992-05-06 2011-03-17 Alcon Laboratories, Inc., Fort Worth Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
US5668133A (en) 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
JP3527256B2 (ja) 1992-12-09 2004-05-17 ロート製薬株式会社 抗アレルギー点眼剤
US5370744B1 (en) * 1993-08-27 1999-11-09 Alcon Lab Inc Process for cleaning and disinfecting contact lenses
US5603929A (en) 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
CN1230882A (zh) * 1996-09-20 1999-10-06 博士伦公司 再湿润隐形眼镜和减轻眼部干燥的方法和组合物
ZA9811445B (en) * 1997-12-19 1999-08-16 Alcon Lab Inc Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
WO1999051273A1 (en) * 1998-04-07 1999-10-14 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
JP3407654B2 (ja) * 1998-04-14 2003-05-19 ライオン株式会社 眼科用組成物
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions

Also Published As

Publication number Publication date
ATE291913T1 (de) 2005-04-15
CA2395866C (en) 2009-10-13
CA2395866A1 (en) 2001-08-02
AU776789B2 (en) 2004-09-23
DE60109742D1 (de) 2005-05-04
US6375973B2 (en) 2002-04-23
US20010056093A1 (en) 2001-12-27
EP1250133B1 (en) 2005-03-30
JP2003520813A (ja) 2003-07-08
ES2236180T3 (es) 2005-07-16
JP2011132259A (ja) 2011-07-07
DE60109742T2 (de) 2005-08-18
AU3455601A (en) 2001-08-07
WO2001054687A1 (en) 2001-08-02
EP1250133A1 (en) 2002-10-23

Similar Documents

Publication Publication Date Title
DE60109742D1 (de) Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
NO20030703D0 (no) Myke forflyttingskontaktlinser for presbyopi
FR2704327B1 (fr) Paire de lentilles ophtalmiques multifocales progressives.
NO995946D0 (no) Formede oftalmiske linser
MY119229A (en) Progressive addition lenses having regrassive surfaces
BRPI0109443B1 (pt) hidrogel de silicone umectÁvel, lentes oftÁlmicas e mÉtodo de preparaÇço de um hidrogel de silicone.
AU8676401A (en) Ophthalmic lenses useful in correcting astigmatism and presbyopia
BR0114886A (pt) Lentes intra-oculares e métodos para sua fabricação
EP1454184A4 (en) WRITING AND / OR OUTPUT OF CONTACT LENSES
DE60139390D1 (de) Binokulare linsensysteme
NO20032816D0 (no) Kontaktlinse med opakt irismönster
AU2001283386A1 (en) Presbyopia treatment by lens alteration
ECSP044862A (es) Pirenzepine ophthalmic gel
NO981151D0 (no) Kontaktlinse med forhöyninger for öyelokk-kontakt
NO20011396D0 (no) Íyebeskyttelse
AR034200A1 (es) Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza
HK1046631A1 (zh) 含有酮替芬的眼药组合物
DE60119166D1 (de) Monomerzusammensetzung, daraus erhaltenes polymer und okularlinse
FR2803922B1 (fr) Lentille ophtalmique
DK1445641T3 (da) Okulære linser
ATE257371T1 (de) Augenspüllösung
SE0001925D0 (sv) Methods of obtaining ophthalmic lenses capable of reducing the aberrations of the eye
EA200300789A1 (ru) Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи
ECSP992838A (es) Lente de contacto multifocal progresiva adecuada para compensacion de la presbiopia
IT1307972B1 (it) Perfezionamento di astina di occhiali con estremita' dotata di mollaelasticizzante.